Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …

Topical ocular preparations are widely recommended by health care professionals, or
chosen by patients, to help manage dry eye disease (DED). The chronic and progressive …

Preservatives continue to be in widespread use in ophthalmic medications due to the
convenience they provide, regulatory requirements and the higher cost of alternatives …

Glaucoma therapy-related ocular surface disease (OSD) is a serious pathology with a broad
spectrum of insidious clinical presentations and complex pathogenesis that undermines …

Preservatives used in topical glaucoma medications have a plethora of well-described toxic
effects on the ocular surface. Such ocular toxicity is manifest clinically as ocular surface …

Poor adherence to topical glaucoma medications has been linked to worse visual field
outcomes in glaucoma patients. Therefore, identifying and overcoming the adherence …

Ocular surface disease (OSD) is a complex condition that can cause a range of symptoms
(eg, dryness, irritation, and pain) and can significantly impact the quality of life of affected …

Topical anti-glaucomatous medications are still the most important measure to lower
intraocular pressure. Large number of studies have confirmed that long-term use of anti …

Dry eye disease (DED) has been found to occur at a higher prevalence in individuals with
glaucoma than in individuals without glaucoma. The relationship between glaucoma and …

Background Use of topical glaucoma medications has been reported to cause ocular
surface (OS) discomfort and inflammation. This study explores the profile of inflammatory …